Two Sigma Securities, LLC In8 Bio, Inc. Transaction History
Two Sigma Securities, LLC
- $10.3 Billion
- Q1 2024
A detailed history of Two Sigma Securities, LLC transactions in In8 Bio, Inc. stock. As of the latest transaction made, Two Sigma Securities, LLC holds 17,557 shares of INAB stock, worth $14,572. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,557Holding current value
$14,572% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding INAB
# of Institutions
32Shares Held
8.62MCall Options Held
0Put Options Held
0-
Aigh Capital Management LLC Baltimore, MD2.87MShares$2.39 Million1.37% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.42MShares$1.18 Million0.0% of portfolio
-
Ensign Peak Advisors, Inc Salt Lake City, UT1.12MShares$928,1600.0% of portfolio
-
683 Capital Management, LLC New York, NY615KShares$510,2450.06% of portfolio
-
Sigma Planning Corp Ann Arbor, MI515KShares$427,5160.02% of portfolio
About IN8BIO, INC.
- Ticker INAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,502,200
- Market Cap $20.3M
- Description
- IN8bio, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of cancers. Its lead product candidate includes INB-200, a genetically modified autologous gamma-delta T cell product candidate that is in Phase I clinical trial for the treatment of...